Stock Events

Stock Events

Lyra Therapeutics (LYRA) Q1 2026 Earnings

31MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-7.5

-5.86

-4.23

-2.59

Details

Expected EPS

-2.59

Actual EPS

-7.14

Surprise EPS

-4.55

Surprise Percent

+175.68%

Description

Lyra Therapeutics (LYRA) has reported earnings of -7.14 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.